A designed antagonist of the thyroid hormone receptor

Hikari A.I. Yoshihara; James W. Apriletti; John D. Baxter; Thomas S. Scanlan

doi:10.1016/S0960-894X(01)00521-2

A designed antagonist of the thyroid hormone receptor

Hikari A.I. Yoshihara, James W. Apriletti, John D. Baxter, Thomas S. Scanlan

Physiology & Pharmacology

Research output: Contribution to journal › Article

31 Scopus citations

Abstract

We synthesized an analogue of the thyromimetic GC-1 bearing the same hydrophobic appendage as the estrogen receptor antagonist ICI-164,384. While having reduced affinity for the thyroid hormone receptors compared to GC-1, it behaves in a manner consistent with a competitive antagonist in a transactivation assay.

Original language	English (US)
Pages (from-to)	2821-2825
Number of pages	5
Journal	Bioorganic & medicinal chemistry letters
Volume	11
Issue number	21
DOIs	https://doi.org/10.1016/S0960-894X(01)00521-2
State	Published - Nov 5 2001

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/S0960-894X(01)00521-2

Fingerprint Dive into the research topics of 'A designed antagonist of the thyroid hormone receptor'. Together they form a unique fingerprint.

Cite this

Yoshihara, H. A. I., Apriletti, J. W., Baxter, J. D., & Scanlan, T. S. (2001). A designed antagonist of the thyroid hormone receptor. Bioorganic & medicinal chemistry letters, 11(21), 2821-2825. https://doi.org/10.1016/S0960-894X(01)00521-2

@article{cac2afd7f1a846539f1329c4f012301f,

title = "A designed antagonist of the thyroid hormone receptor",

abstract = "We synthesized an analogue of the thyromimetic GC-1 bearing the same hydrophobic appendage as the estrogen receptor antagonist ICI-164,384. While having reduced affinity for the thyroid hormone receptors compared to GC-1, it behaves in a manner consistent with a competitive antagonist in a transactivation assay.",

author = "Yoshihara, {Hikari A.I.} and Apriletti, {James W.} and Baxter, {John D.} and Scanlan, {Thomas S.}",

year = "2001",

month = nov,

day = "5",

doi = "10.1016/S0960-894X(01)00521-2",

language = "English (US)",

volume = "11",

pages = "2821--2825",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "21",

}

TY - JOUR

T1 - A designed antagonist of the thyroid hormone receptor

AU - Yoshihara, Hikari A.I.

AU - Apriletti, James W.

AU - Baxter, John D.

AU - Scanlan, Thomas S.

PY - 2001/11/5

Y1 - 2001/11/5

N2 - We synthesized an analogue of the thyromimetic GC-1 bearing the same hydrophobic appendage as the estrogen receptor antagonist ICI-164,384. While having reduced affinity for the thyroid hormone receptors compared to GC-1, it behaves in a manner consistent with a competitive antagonist in a transactivation assay.

AB - We synthesized an analogue of the thyromimetic GC-1 bearing the same hydrophobic appendage as the estrogen receptor antagonist ICI-164,384. While having reduced affinity for the thyroid hormone receptors compared to GC-1, it behaves in a manner consistent with a competitive antagonist in a transactivation assay.

UR - http://www.scopus.com/inward/record.url?scp=0035814089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035814089&partnerID=8YFLogxK

U2 - 10.1016/S0960-894X(01)00521-2

DO - 10.1016/S0960-894X(01)00521-2

M3 - Article

C2 - 11597408

AN - SCOPUS:0035814089

VL - 11

SP - 2821

EP - 2825

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 21

ER -